THE EXPERTS FOR SCIENTIFIC COMMUNICATION BEHIND THE LIFE SCIENCE MARKET LEADERS
We help Medical technology-, Biotech and pharmaceutical companies in the process of Products
scientifically validate and faster to the clinic and to the patient to bring. Because innovative products need more than good ideas - they need robust evidence, Clear study strategies and convincing communication.
Faster to market acceptance
Become a clinical standard at an early stage. Take advantage of the decisive time advantage. Those who reach milestones faster, sell earlier, become more visible - and often become the new standard of care.
Evidence that sells
Position your innovation specifically in the healthcare market. Convince doctors, decision-makers and investors with a clear, well-founded study strategy and communication.
Science at the touch of a button
Get 20+ years of experience in biomedical research, study strategy & scientific copywriting directly into your team - no overhead, no training period, immediately effective.
We create resultsthat can be measured - in study progress, sales development and market presence.
We advise, write, coordinate and sharpen - always with the aim of bringing products to clinical relevance and market acceptance more quickly. Scientifically sound. Entrepreneurial thinking.
Whether original clinical work
or review articles - we
design and write
scientific content with
High Impact. For life science
Companies that are professionally
Position at the top
want.
It is no coincidence,
that the best with us work.
Every successful life science company has these 3 secrets understood.
We are in the middle of a global innovation race. And it is not the best product that will prevail - but the company that most effectively combines scientific evidence, market access and communication.
Secret no. 1
Innovations don't just succeed on their own. Whether with KOLs, regulatory authorities or investors - you need a robust study strategy and medical argumentation that creates trust before the competition is on the market.
Secret no. 2
Every month of delay costs market share. Those who reach milestones earlier sell earlier - and become more visible. Time-to-market (TTM) is the biggest lever on the way to becoming a clinical standard.
Secret no. 3
Medical innovations are only convincing when their results have been published - clearly, cleanly and peer-reviewed. What is not published does not count - neither in guidelines nor with opinion leaders. Without a publication strategy, there is no standing, no success.
Most companies lose valuable time due to a lack of internal resources or science,
approval and sales are not in line and thus miss their unique opportunity.
ABOUT THE COLLABORATION WITH US
Life science communication with clinical impact
As your external partner for scientific communication, publications and strategic medical positioning, we help you to make your clinical innovation visible more quickly - and to anchor it in the market in the long term.
Your advantages
Increase your Clinical Adoption Rate (CAR)
By targeting your customers and the medical audience - with robust data, clear language and content that builds trust so that your product is used and recommended more quickly.
Your innovation becomes visible faster
A professional study strategy and strategic communication shorten the time it takes for your product to be noticed and understood - by doctors, KOLs, investors and specialist media.
Shorten your time to publication (TTP)
Excellent data - but no time or structure to publish it? We take care of the entire process, from manuscript to submission, so that your results get to where they matter.
more Advantages
Immediately available life science know-how
You get 20 years of experience from research, clinic and industry - without training period, without without frictional losses. You benefit from immediately ready-to-use know-how at top level.
Immediate relief for your team
Your teams gain freedom for operational priorities and strategic development. We take on tasks for Medical Affairs, Clinical, Marketing/Sales and Management - efficiently and reliably.
Access to established networks & KOLs
Significantly increase your visibility in the medical community. We have established contacts in hospitals, science and industry - both nationally and internationally - which we always bring to the table.
Higher success rate for admission and adoption
Your innovation receives the visibility and acceptance it deserves. We deliver robust evidence that counts in clinical guidelines, KOL discussions and approval processes.
Transparent, measurable results from experts
You receive clear results that are comprehensible. We are a team of copywriters, statisticians & marketing experts and work in a data-based, strategic and targeted manner.
A strategic partner - not just a service provider
You gain a sparring partner who understands your business - and drives it forward. We think along with you, provide impetus and support you and your project with entrepreneurial vision.
Leading life science companies commission us for these areas
Testimonialsthat speak for themselves
Dr. Jörg Scheier
Vice President Medical Critical Care, CytoSorbents Europe GmbH
"Dr. Recknagel has been a key partner for us in scientific communication for many years. His ability to deal with medical and scientific content in a structured, comprehensible and highly professional manner makes him particularly valuable in our field of intensive care medicine and cardiac surgery. Whether in the preparation and publication of scientific data or in strategic coordination - he is a reliable and professionally strong partner who has supported us effectively in numerous projects and will continue to do so. Our long-standing cooperation with Dr. Recknagel is characterized by a high degree of trust, consistently high quality and professional sovereignty.
He understands our topics, our target groups - and always delivers exactly what we need. I can recommend working with Dr. Recknagel without reservation - professionally, strategically and personally."
Dr. med. Klaus Kogelmann
Former Chief Physician, Department of Anesthesiology and Intensive Care Medicine, Emden Hospital
"Dear Peter, it is a pleasure to write you a reference. In more than 10 years of scientific collaboration, Dr. Peter Recknagel was a congenial partner for me and always extremely helpful as my eyes and ears in our projects. We were able to publish our joint projects in a timely and targeted manner, with clear agreements on the roadmap and ultimately always at a high level. It is therefore a pleasure for me to enjoy this highly efficient and friendly collaboration and clearly recommend it to others."
Tobias Schwert
Therapy Development Manager, Heart Failure Department, Mechanical circulatory support
Abbott Medical GmbH
"Working with Peter is simply great. His quick understanding of different therapeutic approaches - including the respective technologies, indications and their limitations - is outstanding. In combination with his drive and efficiency, our joint projects (and there were several) were not only implemented at a high level, but were also a real pleasure."
The Management
Dr. Peter Recknagel
Founder & Managing Director
SCILS | Science Consulting in Life Science
With over two decades of experience in research, clinical practice, industry and international consulting, Dr. Peter Recknagel is one of the most distinguished scientific and strategic minds in the life sciences sector. He holds a doctorate in biomedicine (Dr. rer. nat.) and has worked at leading research institutions such as University College London and Jena University Hospital - including in the fields of intensive care medicine, sepsis research and molecular biomedicine.
Since 2012, he has been an independent consultant to medtech, pharma and biotech companies on clinically and scientifically sound market entries, medical affairs, study strategy and the publication of high-quality scientific content. Over 100 publications, case reports and specialist texts are the result of his leadership or involvement.
Dr. Recknagel combines scientific excellence with entrepreneurial clarity. As a strategic sparring partner, he works at the interface between research, clinical practice and the market - for life science companies that not only want to impress with their products, but also set standards. "My job is to translate scientific depth into impact - in studies, communication and strategy.
The course of our cooperation:
OUR STRUCTURED 5-STEP PROCESS FOR SCIENTIFIC MARKET LEADERSHIP
STEP 1: STRATEGIC ONBOARDING
We start with a structured onboarding process: the aim is to clearly understand the product, clinical context, project goals and internal expectations. We use a short briefing format and coordinate directly with relevant departments such as Medical, Regulatory or Marketing.
➞ This creates a common understanding of content, tone and objectives right from the start.
STEP 2: ANALYSIS & TARGET GROUP FOCUS
We analyze the initial scientific situation, relevant studies and market requirements. At the same time, we sharpen the target group focus - be it for physicians, KOLs, investors, sales or regulatory authorities.
➞ The result: clear, target group-oriented communication that makes an impact.
STEP 3: RESEARCH & DATA PREPARATION
We research current literature, clinical guidelines, study results and relevant data. These are processed, contextualized and compared with existing statements.
➞ In this way, we ensure scientific substance, argumentative power and connectivity to current discourses.
STEP 4: CONCEPT & CONTENT IMPLEMENTATION
Based on strategy and data, we design content that is well-founded, understandable and effective. Whether study communication, specialist articles, white papers or training documents: the content follows the function.
➞ We formulate scientifically precise and at the same time target-oriented for clinical, regulatory and market-oriented contexts.
STEP 5: QUALITY CHECK & ON-TIME DELIVERY
Every piece of content goes through our structured quality control process. We check for scientific coherence, linguistic clarity, regulatory compliance and adherence to objectives.
➞ The end result is a reliable result that is publishable, citable and effective. On time. Without rework.
FAQ - YOU HAVE OPEN QUESTIONS?
What exactly does SCILS do?
SCILS specializes in scientific-strategic consulting and communication for companies in the life sciences sector. We support our clients in study strategy, publication planning, medical copywriting and scientifically sound market communication - with the aim of establishing medical innovations on the market faster and more convincingly.
For whom does the collaboration make sense?
SCILS specializes in scientific-strategic consulting and communication for companies in the life sciences sector. We support our clients in study strategy, publication planning, medical copywriting and scientifically sound market communication - with the aim of establishing medical innovations on the market faster and more convincingly.
What kind of projects does SCILS take on?
Among other things, we look after
- Study strategy & study support: Development, initiation and coordination of national and international studies - both clinical and basic scientific.
- Scientific Marketing & Evidence Analysis: Research, evaluation and strategic preparation of scientific data for targeted product positioning
- Medical & Scientific Writing: Preparation, revision and publication of case reports, studies, reviews - including monitoring of the peer review process through to final publication
- Training & presentation content: Conception and design of high-quality lectures, training materials and medical sales presentations
- Target group work & communication: Scientific support for sales teams, training, workshops and cooperation with KOLs and advisory boards
- Data, literature & survey work: conducting and evaluating medical research and surveys - as a basis for communication, studies or market analysis
- Technical documentation & meeting support: creation of meeting minutes, summaries of symposia and scientific events
- Translations & language adaptations: Professional and precise translation of scientific content (German-English / English-German) for international visibility.
How does the collaboration work?
What results can I expect?
You receive reliable, scientifically sound content - precisely formulated, publishable at a high level and effective in the market. Whether publication, presentation or study communication: impact is our goal.
How confidential is the collaboration?
Absolutely confidential. We have been working with sensitive, project-related data for many years. Of course, we offer an NDA or individual confidentiality agreement on request.
How long does a project take?
This depends on the scope. We usually deliver shorter text formats (e.g. white papers, abstracts) in 1-2 weeks. Extensive study or publication projects take correspondingly longer - always with a clear timeline and punctual delivery.
